SEC Comment Letter for HNO International, Inc. (HNOI) (CIK 0001342916) (HNOI) — Mar 18, 2011
HNO International, Inc. (HNOI) (CIK 0001342916)
Date: March 18, 2011 · CIK: 0001342916 · Accession: 0000000000-11-016986
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-130286
Referenced dates: March 8, 2011
Letter
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549-7010
DIVISION OF CORPORATION FINANCE March 18, 2011
Mark Quinn Executive Chairman Clenergen Corporation Bath House, 8 Chapel Place Rivington Road, London, U.K. EC2A 3DQ Re: Clenergen Corporation Form 10-K for the Fiscal Year Ended October 31, 2010 Filed February 14, 2011 File No. 333-130286 Response Letter Filed March 17, 2011 Dear Mr. Quinn:
We have reviewed your response letter and have the following comments. Please respond to this letter within te n business days by providing the requested information, or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circum stances, please tell us w hy in your response. After reviewing the information you provide in response to these comments, we may have additional comments. General
1. Please refer to comment 1 in our letter da ted March 8, 2011. We note your response that you have cancelled any license rights and ag reements in Cuba and that you have no business interest “in these three countries.” Please tell us whether you had any contacts with Cuba before entering into the agreem ent with BioPower Corporation on November 30, 2010 or during the period between the signi ng of the agreement and the cancellation of the license rights related to Cuba, and whether you intend to have any future contacts with Cuba. Similarly, tell us whether you prev iously had, currently have, or anticipate having any contacts with Iran, Sudan, or Syria. If so, please provide us the information regarding your contacts with Iran, Sudan, and Syria we requested in comments 2 and 3 of our previous letter. 2. Please furnish in your response letter the written statement from the company we requested at the end of the second pa ge of our letter dated March 8, 2011.
Mark Quinn Clenergen Corporation March 18, 2011 Page 2 Please contact Pradip Bhaumik, Special Couns el, at (202) 551-3333 or me at (202) 551- 3470 if you have any questions abou t the comments or our review. S i n c e r e l y , C e c i l i a B l y e , C h i e f Office of Global Security Risk cc: Roger Schwall Assistant Director Division of Cor poration Finance
Show Raw Text
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549-7010
DIVISION OF
CORPORATION FINANCE
March 18, 2011
Mark Quinn Executive Chairman
Clenergen Corporation
Bath House, 8 Chapel Place Rivington Road, London, U.K. EC2A 3DQ
Re: Clenergen Corporation
Form 10-K for the Fiscal Year Ended October 31, 2010
Filed February 14, 2011 File No. 333-130286 Response Letter Filed March 17, 2011
Dear Mr. Quinn:
We have reviewed your response letter and have the following comments.
Please respond to this letter within te n business days by providing the requested
information, or by advising us when you will provide the requested response. If you do not believe our comments apply to your facts and circum stances, please tell us w hy in your response.
After reviewing the information you provide in response to these comments, we may
have additional comments. General
1. Please refer to comment 1 in our letter da ted March 8, 2011. We note your response that
you have cancelled any license rights and ag reements in Cuba and that you have no
business interest “in these three countries.” Please tell us whether you had any contacts
with Cuba before entering into the agreem ent with BioPower Corporation on November
30, 2010 or during the period between the signi ng of the agreement and the cancellation
of the license rights related to Cuba, and whether you intend to have any future contacts
with Cuba. Similarly, tell us whether you prev iously had, currently have, or anticipate
having any contacts with Iran, Sudan, or Syria. If so, please provide us the information
regarding your contacts with Iran, Sudan, and Syria we requested in comments 2 and 3 of
our previous letter.
2. Please furnish in your response letter the written statement from the company we
requested at the end of the second pa ge of our letter dated March 8, 2011.
Mark Quinn
Clenergen Corporation March 18, 2011 Page 2
Please contact Pradip Bhaumik, Special Couns el, at (202) 551-3333 or me at (202) 551-
3470 if you have any questions abou t the comments or our review.
S i n c e r e l y , C e c i l i a B l y e , C h i e f Office of Global Security Risk cc: Roger Schwall Assistant Director Division of Cor poration Finance